TerrAscend (TSNDF) Cash & Current Investments (2021 - 2026)
TerrAscend (TSNDF) reported Cash & Current Investments of $472000.0 for Q1 2026, down 56.89% year-over-year from $1.1 million in Q1 2025, and little changed quarter-over-quarter from $472000.0 in Q4 2025.
TerrAscend (TSNDF) Cash & Current Investments (2021 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 6 years of Cash & Current Investments data on file, last reported at $472000.0 in Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $472000.0, down 56.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $472000.0 (down 56.89% YoY), and the FY2025 annual result was $472000.0, down 79.77% from the prior year.
- Cash & Current Investments steadied at $472000.0 in Q1 2026 per TSNDF's latest filing, from $472000.0 in the prior quarter.
- Over five years, Cash & Current Investments peaked at $92.5 million in Q1 2022 and troughed at $472000.0 in Q4 2025.
- A 5-year average of $25.4 million and a median of $27.3 million in 2023 frame the typical range for Cash & Current Investments.
- On a YoY basis, Cash & Current Investments climbed as much as 470.39% in 2025 and fell as far as 95.55% in 2025.
- A 5-year view of Cash & Current Investments shows it stood at $29.8 million in 2022, then fell by 18.82% to $24.2 million in 2023, then tumbled by 90.34% to $2.3 million in 2024, then plunged by 79.77% to $472000.0 in 2025, then changed by 0.0% to $472000.0 in 2026.
- Business Quant data shows TSNDF's Cash & Current Investments at $472000.0 in Q1 2026, $472000.0 in Q4 2025, and $37.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 750.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 498.58 Mn |
| 10 | TerrAscend | - | - | 34.60 Mn | 472,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 472,000.00 |
| Dec 31, 2025 | 472,000.00 |
| Sep 30, 2025 | 37.51 Mn |
| Jun 30, 2025 | 27.66 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 2.33 Mn |
| Sep 30, 2024 | 28.39 Mn |
| Jun 30, 2024 | 4.85 Mn |
| Mar 31, 2024 | 24.63 Mn |
| Dec 31, 2023 | 24.15 Mn |
| Sep 30, 2023 | 27.33 Mn |
| Jun 30, 2023 | 5.04 Mn |
| Mar 31, 2023 | 34.96 Mn |
| Dec 31, 2022 | 29.75 Mn |
| Sep 30, 2022 | 37.84 Mn |
| Jun 30, 2022 | 52.50 Mn |
| Mar 31, 2022 | 92.53 Mn |
| Dec 31, 2021 | 79.64 Mn |